Group One Trading’s Haemonetics HAE Stock Holding History

Group One Trading’s Portfolio HAE Stock Details HAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-1,000	Closed	-$63.5K	–	8202
2025 Q1	$63.5K	Sell	1,000 -11,300	-92%	-$769K	﹤0.01%	4963
2024 Q4	$960K	Buy	+12,300	New	+$988K	﹤0.01%	2612
2024 Q3	–	Sell	-100	Closed	-$8.27K	–	6907
2024 Q2	$8.27K	Hold	100	–	–	﹤0.01%	5728
2024 Q1	$8.54K	Buy	+100	New	+$7.85K	﹤0.01%	5953
2023 Q1	–	Sell	-3,000	Closed	-$236K	–	7491
2022 Q4	$236K	Buy	+3,000	New	+$241K	﹤0.01%	3722
2022 Q3	–	Sell	-300	Closed	-$20K	–	7781
2022 Q2	$20K	Buy	+300	New	+$17.8K	﹤0.01%	6282
2022 Q1	–	Sell	-800	Closed	-$42K	–	8272
2021 Q4	$42K	Sell	800 -300	-27%	-$18.3K	﹤0.01%	6462
2021 Q3	$78K	Sell	1,100 -800	-42%	-$50.5K	﹤0.01%	6159
2021 Q2	$127K	Buy	+1,900	New	+$134K	﹤0.01%	5719
2014 Q3	–	Sell	-2,200	Closed	-$78K	–	5264
2014 Q2	$78K	Buy	2,200 +1,000	+83%	+$33.4K	﹤0.01%	3208
2014 Q1	$39K	Buy	+1,200	New	+$45.9K	﹤0.01%	3807

Other funds holding HAE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

RRAM

River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Group One Trading's HAE Position: Q1 2026 in Review

Group One Trading reduced its Haemonetics (HAE) stake by 83% in Q1 2026, selling an estimated $156K and leaving 477 shares worth $26.9K. The position accounts for ﹤0.01% of the portfolio, ranked #5761.

Group One Trading first reported a position in HAE in Q1 2014 and has held it in 13 quarters since. The position peaked at $230K in Q4 2025. 324 funds tracked by Wall St. Rank hold HAE as of Q1 2026.

Group One Trading held 477 shares of Haemonetics worth $26.9K as of Q1 2026.
Group One Trading sold 2,392 Haemonetics shares in Q1 2026, an estimated $156K.
Haemonetics made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #5761 holding.
Group One Trading first reported a position in Haemonetics in Q1 2014 and has held it in 13 quarters since.
Group One Trading's Haemonetics position peaked at $230K in Q4 2025.
324 funds tracked by Wall St. Rank held Haemonetics as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.